Literature DB >> 18535250

Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.

Markus Diefenbacher1, Sylwia Sekula, Christine Heilbock, Jana V Maier, Margarethe Litfin, Hans van Dam, Marc Castellazzi, Peter Herrlich, Olivier Kassel.   

Abstract

The term activator protein (AP)-1 describes homodimeric and heterodimeric transcription factors composed of members of the Jun, Fos, and cAMP response element-binding protein (CREB)/activating transcription factor (ATF) families of proteins. Distinct AP-1 dimers, for instance the prototypical c-Jun:c-Fos and c-Jun:ATF2 dimers, are differentially regulated by signaling pathways and bind related yet distinct response elements in the regulatory regions of AP-1 target genes. Little is known about the dimer-specific regulation of AP-1 activity at the promoter of its target genes. We have previously shown that nTrip6, the nuclear isoform of the LIM domain protein Trip6, acts as an AP-1 coactivator. Moreover, nTrip6 is an essential component of glucocorticoid receptor (GR)-mediated trans-repression of AP-1, in that it mediates the tethering of GR to the promoter-bound AP-1. We have now discovered a striking specificity of nTrip6 actions determined by the binding preference of its LIM domains. We show that nTrip6 interacts only with Fos family members. Consequently, nTrip6 is a selective coactivator for AP-1 dimers containing Fos. nTrip6 also assembles activated GR to c-Jun:c-Fos-driven promoters. Neither nTrip6 nor GR are recruited to a promoter occupied by c-Jun:ATF2. Thus, only Fos-containing dimers are trans-repressed by GR. Thus, the dimer composition of AP-1 determines the mechanism of both the positive and negative regulation of AP-1 transcriptional activity. Interestingly, on a second level of action, GR represses the increase in transcriptional activity of c-Jun:ATF2 induced by c-Jun N-terminal kinase (JNK)-dependent phosphorylation. This repression depends on GR-mediated induction of MAPK phosphatase 1 (MKP-1) expression, which results in c-Jun N-terminal kinase inactivation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535250      PMCID: PMC2505324          DOI: 10.1210/me.2007-0574

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  88 in total

1.  Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation.

Authors:  Chang-Deng Hu; Yurii Chinenov; Tom K Kerppola
Journal:  Mol Cell       Date:  2002-04       Impact factor: 17.970

2.  Cascade of distinct histone modifications during collagenase gene activation.

Authors:  Joost H A Martens; Matty Verlaan; Eric Kalkhoven; Alt Zantema
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 3.  AP-1: a double-edged sword in tumorigenesis.

Authors:  Robert Eferl; Erwin F Wagner
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

4.  Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2.

Authors:  Akira Imasato; Christéle Desbois-Mouthon; Jiahuai Han; Hirofumi Kai; Andrew C B Cato; Shizuo Akira; Jian-Dong Li
Journal:  J Biol Chem       Date:  2002-09-27       Impact factor: 5.157

5.  TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor.

Authors:  Jun Xu; Yun-Ju Lai; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

6.  JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun.

Authors:  Carsten Weiss; Sandra Schneider; Erwin F Wagner; Xiaohong Zhang; Edward Seto; Dirk Bohmann
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

7.  Amplification of plasmids containing a mammalian replication initiation region is mediated by controllable conflict between replication and transcription.

Authors:  Noriaki Shimizu; Toshihiko Hashizume; Kenta Shingaki; June-ko Kawamoto
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

8.  A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation.

Authors:  Sumito Ogawa; Jean Lozach; Kristen Jepsen; Dominique Sawka-Verhelle; Valentina Perissi; Roman Sasik; David W Rose; Randall S Johnson; Michael G Rosenfeld; Christopher K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-27       Impact factor: 11.205

9.  Promoter specificity and biological activity of tethered AP-1 dimers.

Authors:  Latifa Bakiri; Koichi Matsuo; Marta Wisniewska; Erwin F Wagner; Moshe Yaniv
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids.

Authors:  Alejandra Bruna; Marta Nicolàs; Alberto Muñoz; John M Kyriakis; Carme Caelles
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

View more
  26 in total

Review 1.  Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.

Authors:  Christopher K Glass; Kaoru Saijo
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

Review 2.  Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.

Authors:  Karolien De Bosscher; Guy Haegeman
Journal:  Mol Endocrinol       Date:  2008-12-18

Review 3.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 4.  Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.

Authors:  Robert Newton; Suharsh Shah; Mohammed O Altonsy; Antony N Gerber
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

Review 5.  Understanding how long-acting β2 -adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update.

Authors:  Robert Newton; Mark A Giembycz
Journal:  Br J Pharmacol       Date:  2016-11-09       Impact factor: 8.739

Review 6.  Nuclear receptors in inflammation control: repression by GR and beyond.

Authors:  Yurii Chinenov; Rebecca Gupte; Inez Rogatsky
Journal:  Mol Cell Endocrinol       Date:  2013-04-26       Impact factor: 4.102

Review 7.  There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor.

Authors:  Franziska Greulich; M Charlotte Hemmer; David A Rollins; Inez Rogatsky; N Henriette Uhlenhaut
Journal:  Steroids       Date:  2016-05-15       Impact factor: 2.668

8.  How transcription proceeds in a large artificial heterochromatin in human cells.

Authors:  Koh-ichi Utani; Noriaki Shimizu
Journal:  Nucleic Acids Res       Date:  2008-11-29       Impact factor: 16.971

9.  Episomal high copy number maintenance of hairpin-capped DNA bearing a replication initiation region in human cells.

Authors:  Seiyu Harada; Masafumi Uchida; Noriaki Shimizu
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

10.  Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling: DEPENDENCE ON DNA SEQUENCE, MR CONFORMATION, AND AP-1 FAMILY MEMBER EXPRESSION.

Authors:  Edward J Dougherty; Jason M Elinoff; Gabriela A Ferreyra; Angela Hou; Rongman Cai; Junfeng Sun; Kevin P Blaine; Shuibang Wang; Robert L Danner
Journal:  J Biol Chem       Date:  2016-09-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.